Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Receivables (2016 - 2025)

Historic Change in Receivables for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $575000.0.

  • InspireMD's Change in Receivables rose 15784.75% to $575000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $431000.0, marking a year-over-year increase of 2456.65%. This contributed to the annual value of -$232000.0 for FY2024, which is 13012.99% down from last year.
  • Latest data reveals that InspireMD reported Change in Receivables of $575000.0 as of Q3 2025, which was up 15784.75% from -$77000.0 recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Change in Receivables peaked at $620000.0 during Q4 2023, and registered a low of -$617000.0 during Q1 2024.
  • In the last 5 years, InspireMD's Change in Receivables had a median value of $53000.0 in 2023 and averaged $78157.9.
  • In the last 5 years, InspireMD's Change in Receivables soared by 60303.03% in 2021 and then crashed by 158235.29% in 2023.
  • InspireMD's Change in Receivables (Quarter) stood at $253000.0 in 2021, then crashed by 152.17% to -$132000.0 in 2022, then soared by 569.7% to $620000.0 in 2023, then crashed by 93.23% to $42000.0 in 2024, then surged by 1269.05% to $575000.0 in 2025.
  • Its last three reported values are $575000.0 in Q3 2025, -$77000.0 for Q2 2025, and -$109000.0 during Q1 2025.